Datwyler in the news.

In May, Project Jumpstart, a public-private initiative, was announced that will pump $138 million into the production of 100 million prefilled syringes by the end of this year and another 500 million in 2021, should a COVID-19 vaccine become available. Yet, industry gurus do not necessarily agree that the pandemic will have a positive impact on the injection delivery market. Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the important role that coated plungers play in ensuring the appropriate functionality and compatibility of injection devices.

When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.

«When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.

Carina Van Eester explores the benefits of fully coated plungers for prefilled syringes and cartridges.

Plunger Designed with Functionality in Mind.

The growth of injectables, personalized medicine, anti-counterfeiting measures, and automation are a few trends that may follow the industry into a new normal.

Rahul Thakar, PhD, technical key account manager at Datwyler Pharma, discusses the rise of injectables, quality control measures, and personalization.

Datwyler has launched its NeoFlex plungers to help developers better protect the integrity of injectable formulations and optimise the functionality of prefilled syringes and cartridge.

Container closure integrity (CCI) is an increasingly relevant issue in the pharmaceutical packaging industry. It addresses the maintenance of integrity to prevent microbial ingress in sterile product packaging until the time of use, as well as to restrict the loss of product contents and to prevent the entry of detrimental gases or other materials.

With the advent of biologics and highly sensitive drugs, primary packaging materials must meet the highest-level of functional, regulatory and cleanliness standards to ensure compatibility and ultimately, patient safety. Rahul Thakar, PhD, discusses Datwyler's solution to these ever-stricter requirements is their highest-quality manufacturing standard, FristLine™.